한글목차

외골격 시장 규모는 2025년에 5억 6,000만 달러로 추정되며, 2030년에는 20억 3,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 29.4%의 CAGR을 기록할 것으로 예상됩니다.

외골격은 신체 장애인의 운동 능력을 향상시키고 산업 노동자의 신체적 부담을 줄이기 위해 중요하며, 의료 및 제조 산업에서 외골격의 통합으로 이어지고 있습니다. 노인 인구가 증가하고 재활을 위한 재택 환자가 증가함에 따라 외골격의 필요성은 점점 더 커지고 있습니다. 더 많은 기술(AI, 센서, 경량 소재)을 사용할 수 있게 되면 외골격 제품은 더 잘 작동하고, 더 저렴하고, 더 쉽게 구할 수 있게 될 것입니다. 제품 개발 과정과 국제 외골격 시장의 성장은 민관 모두의 지속적인 투자를 통해서만 개선될 수 있습니다.

전동식 외골격 시장은 투자자들의 신뢰와 상업화 가능성을 뒷받침하는 중요한 자금 조달 활동으로 인해 가속화된 성장세를 보이고 있습니다. 예를 들어, 2023년 12월 전동식 외골격 개발 업체인 저먼 바이오닉(German Bionic)은 확장 시리즈 A 펀딩 라운드에서 1,630만 달러 이상의 자금을 확보했습니다. 이 자금 조달은 회사의 산업화 파트너인 Mbea와의 협력 관계를 강화하고 생산 규모를 확대하며 배포 능력을 향상시키는 것을 목표로합니다. 같은 달, 캠브리지에 본사를 둔 스타트업 Verve Motion은 가혹한 작업에 종사하는 근로자의 신체 능력을 강화하기 위해 설계된 로봇형 외투를 전문으로 하는 스타트업으로 시리즈 B 펀딩 라운드에서 2,000만 달러의 자금을 성공적으로 조달했습니다. 이러한 추세는 동력식 외골격 기술에 대한 전략적 투자라는 광범위한 추세를 반영하는 것으로, 산업 자동화, 부상 예방, 노동력 강화 등 다양한 분야에서 실행 가능한 솔루션으로 자리매김하고 있습니다.

산업 부문은 노동 집약적인 환경에서 근로자의 안전, 피로 감소, 생산성 향상에 대한 필요성으로 인해 외골격 기술의 중요한 채택자로 빠르게 부상하고 있습니다. 외골격은 제조업, 창고업, 물류업, 조립 라인 등 작업자가 반복적으로 들어올리고, 구부리고, 머리 위에서 작업하는 경우가 많은 산업에서 특히 유용합니다. 허리, 어깨, 다리를 지원함으로써 근골격계 부상의 위험을 줄이는 데 도움이 되는 웨어러블 기기입니다.

독일은 강력한 산업 수요, 의료 분야의 혁신, 대규모 민간 투자에 힘입어 유럽에서 가장 선진적이고 성숙한 외골격 기술 시장 중 하나입니다. 독일의 탄탄한 제조업과 물류 부문은 노동 효율성을 개선하고 근골격계 부상을 줄이기 위해 외골격을 적극적으로 채택하고 있습니다. 국내 최고의 개발 기업 중 하나인 독일 바이오닉(German Bionic)은 이러한 추세를 상징하는 기업으로, 2023년 12월 시리즈 A 펀딩 라운드에서 1,630만 달러 이상의 자금을 조달하여 제품 포트폴리오를 확장했습니다. 이 회사의 외골격인 Apogee와 Apogee+는 물류, 소매, 헬스케어 분야에서 리프팅, 보행, 자세 교정을 보조하는 데 사용되고 있습니다. 이러한 커넥티드 웨어러블은 독일의 주요 산업에서 작업장 인체공학을 재정의하는 데 기여하고 있습니다.

세계의 외골격 시장에 대해 조사했으며, 재료별, 구조별, 모빌리티별, 신체 부위별, 구성요소별, 유형별, 산업별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 밸류체인 분석
• 생태계 분석
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 기술 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 사례 연구 분석
• 투자와 자금 조달 시나리오
• 무역 분석, 2020-2024년
• 특허 분석
• 2025-2026년의 주요 회의와 이벤트
• 관세와 규제 상황
• AI가 외골격 시장에 미치는 영향
• 2025년 미국 관세가 외골격 시장에 미치는 영향

제6장 외골격 시장(재료별)

• 소개
• 탄소섬유
• 금속
• 강 합금
• 알루미늄

제7장 외골격 시장(구조별)

• 소개
• 경질 외골격
• 소프트 외골격

제8장 외골격 시장(모빌리티별)

• 소개
• 고정형
• 가동형

제9장 외골격 시장(신체 부위별)

• 소개
• 하지
• 상지
• 풀 바디

제10장 외골격 시장(구성요소별)

• 소개
• 센서
• 액추에이터
• 전원
• 제어 시스템
• 기타

제11장 외골격 시장(유형별)

• 소개
• 동력식 외골격
• 패시브 외골격

제12장 외골격 시장(업계별)

• 소개
• 헬스케어
• 방위
• 산업
• 건설
• 기타

제13장 외골격 시장(지역별)

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 거시경제 전망
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 폴란드
  • 북유럽
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 중국
  • 일본
  • 한국
  • 인도
  • 호주
  • 인도네시아
  • 말레이시아
  • 태국
  • 베트남
  • 기타
• 기타 지역
  • 기타 지역의 거시경제 전망
  • 중동
  • 남미
  • 아프리카
  • 남아프리카공화국
  • 기타

제14장 경쟁 구도

• 개요
• 주요 진출 기업 전략/강점, 2022년 1월-2025년 2월
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2024년
• 기업 평가와 재무 지표, 2024년
• 브랜드/제품 비교
• 기업 평가 매트릭스 : 주요 진출 기업, 2024년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
• 경쟁 시나리오

제15장 기업 개요

• 주요 진출 기업
  • EKSO BIONICS
  • OTTOBOCK
  • DIH MEDICAL
  • COMAU
  • MYOMO INC.
  • CYBERDYNE INC.
  • LIFEWARD LTD.
  • HYUNDAI MOTOR GROUP ROBOTICS LAB.
  • B-TEMIA
  • REX BIONICS LTD.
• 기타 기업
  • ABLE HUMAN MOTION
  • LAEVO EXOSKELETONS
  • GERMAN BIONIC SYSTEMS GMBH
  • LEVITATE TECHNOLOGIES, INC.
  • FOURIER
  • TREXO ROBOTICS
  • WANDERCRAFT
  • AGADE
  • EUROPE TECHNOLOGIES
  • GOGOA.EU
  • ARCHELIS INC.
  • P&S MECHANICS CO., LTD.
  • RB3D
  • JAPET MEDICAL DEVICES
  • PROTESO S.R.L.

제16장 부록

영문목차

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.

"Powered exoskeleton segment to register the highest CAGR during the forecast period."

The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company's collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors.

"Industrial vertical to register the second-highest CAGR during the forecast period."

The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs.

"Germany to dominate European exoskeleton market."

Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country's robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany's key industries.

• By Company Type: Tier 1 - 25%, Tier 2 - 40%, and Tier 3 - 35%
• By Designation: C-level Executives - 30%, Directors - 28%, and Others - 42%
• By Region: North America- 43%, Europe - 15%, Asia Pacific- 37%, and RoW- 05%

Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.

The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem.

Reasons to Buy This Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
• Market Development: Comprehensive information about lucrative markets - the report analyses the exoskeleton market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 INCLUSIONS AND EXCLUSIONS
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 LIMITATIONS
• 1.7 STAKEHOLDERS
• 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of major secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Intended participants and key opinion leaders in primary interviews
    • 2.1.2.2 List of major participants in primary interviews
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
  • 2.1.3 SECONDARY AND PRIMARY RESEARCH
    • 2.1.3.1 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
  • 2.2.2 TOP-DOWN APPROACH
    • 2.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET
• 4.2 EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL
• 4.3 EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL
• 4.4 EXOSKELETON MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising demand for robotic rehabilitation solutions from healthcare sector
    • 5.2.1.2 Increased adoption in industrial and manufacturing sectors
    • 5.2.1.3 Increased FDA approvals for medical exoskeletons
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of ownership
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration of exoskeletons with AI and IoT technologies
    • 5.2.3.2 Increasing adoption of exoskeletons in military and defense sectors
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Comfort and movement interference for workers
    • 5.2.4.2 Power supply limitations and operational downtime
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.6 PRICING ANALYSIS
  • 5.6.1 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024
  • 5.6.2 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022-2024
  • 5.6.3 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022-2024
  • 5.6.4 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022-2024
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Actuators and motors
    • 5.7.1.2 Sensors and feedback systems
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 IoT connectivity
    • 5.7.2.2 AI and ML
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Artificial muscles
    • 5.7.3.2 Physical therapy equipment
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8.2 BARGAINING POWER OF SUPPLIERS
  • 5.8.3 BARGAINING POWER OF BUYERS
  • 5.8.4 THREAT OF SUBSTITUTES
  • 5.8.5 THREAT OF NEW ENTRANTS
• 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.9.2 BUYING CRITERIA
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU'S MATE-XT WEARABLE EXOSKELETON
  • 5.10.2 ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY
  • 5.10.3 ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS
  • 5.10.4 REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK
  • 5.10.5 FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST
• 5.11 INVESTMENT AND FUNDING SCENARIO
• 5.12 TRADE ANALYSIS, 2020-2024
  • 5.12.1 IMPORT SCENARIO (HS CODE 9021)
  • 5.12.2 EXPORT SCENARIO (HS CODE 9021)
• 5.13 PATENT ANALYSIS
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.15 TARIFF AND REGULATORY LANDSCAPE
  • 5.15.1 TARIFF ANALYSIS, 2024
  • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.3 STANDARDS
• 5.16 IMPACT OF AI ON EXOSKELETON MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 AI-SPECIFIC USE CASES
• 5.17 2025 US TARIFF IMPACT ON EXOSKELETON MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARIFF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS
    • 5.17.4.1 US
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 END-USE INDUSTRY IMPACT

6 EXOSKELETON MARKET, BY MATERIAL

• 6.1 INTRODUCTION
• 6.2 CARBON FIBER
  • 6.2.1 GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET
• 6.3 METAL
  • 6.3.1 HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND
• 6.4 STEEL ALLOYS
  • 6.4.1 SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET
• 6.5 ALUMINUM
  • 6.5.1 CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH

7 EXOSKELETON MARKET, BY STRUCTURE

• 7.1 INTRODUCTION
• 7.2 RIGID EXOSKELETONS
  • 7.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
• 7.3 SOFT EXOSKELETONS
  • 7.3.1 INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET

8 EXOSKELETON MARKET, BY MOBILITY

• 8.1 INTRODUCTION
• 8.2 STATIONARY
  • 8.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
• 8.3 MOBILE
  • 8.3.1 RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET

9 EXOSKELETON MARKET, BY BODY PART

• 9.1 INTRODUCTION
• 9.2 LOWER EXTREMITIES
  • 9.2.1 RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND
• 9.3 UPPER EXTREMITIES
  • 9.3.1 ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET
• 9.4 FULL BODY
  • 9.4.1 ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND

10 EXOSKELETON MARKET, BY COMPONENT

• 10.1 INTRODUCTION
• 10.2 SENSORS
  • 10.2.1 INTEGRATION OF AI AND ML TO BOOST DEMAND
  • 10.2.2 GYROSCOPES
  • 10.2.3 ACCELEROMETERS
  • 10.2.4 TILT SENSORS
  • 10.2.5 FORCE/TORQUE SENSORS
  • 10.2.6 POSITION SENSORS
  • 10.2.7 ELECTROMYOGRAPHY SENSORS
• 10.3 ACTUATORS
  • 10.3.1 COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET
• 10.4 POWER SOURCES
  • 10.4.1 ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET
• 10.5 CONTROL SYSTEMS
  • 10.5.1 ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET
• 10.6 OTHER COMPONENTS

11 EXOSKELETON MARKET, BY TYPE

• 11.1 INTRODUCTION
• 11.2 POWERED EXOSKELETON
  • 11.2.1 RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH
  • 11.2.2 POWERED EXOSKELETONS, BY TECHNOLOGY
    • 11.2.2.1 Advancements in battery technology and energy-efficient actuators to fuel market growth
    • 11.2.2.2 Electric
    • 11.2.2.3 Pneumatic
    • 11.2.2.4 Hydraulic
• 11.3 PASSIVE EXOSKELETON
  • 11.3.1 INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION

12 EXOSKELETON MARKET, BY VERTICAL

• 12.1 INTRODUCTION
• 12.2 HEALTHCARE
  • 12.2.1 RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT
  • 12.2.2 REHABILITATION
  • 12.2.3 DISABILITY ASSISTANCE
  • 12.2.4 ELDERLY CARE
• 12.3 DEFENSE
  • 12.3.1 INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH
  • 12.3.2 ENHANCED MOBILITY
  • 12.3.3 INJURY PREVENTION
  • 12.3.4 STEALTH AND TACTICAL OPERATIONS
• 12.4 INDUSTRIAL
  • 12.4.1 INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET
  • 12.4.2 HEAVY LIFTING
  • 12.4.3 REPETITIVE TASK ASSISTANCE
  • 12.4.4 POSTURAL SUPPORT
  • 12.4.5 LOGISTICS
  • 12.4.6 MATERIAL HANDLING
• 12.5 CONSTRUCTION
  • 12.5.1 INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS
  • 12.5.2 LIFTING ASSISTANCE
  • 12.5.3 ENHANCED PRODUCTIVITY AND EFFICIENCY
• 12.6 OTHER VERTICALS

13 EXOSKELETON MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 Growing military focus on injury prevention and surge in startup funding to drive market
  • 13.2.3 CANADA
    • 13.2.3.1 Government contracts supporting defense applications to boost market
  • 13.2.4 MEXICO
    • 13.2.4.1 Strategic investments in hospital infrastructure to foster revenue growth
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 UK
    • 13.3.2.1 Government support through defense innovation program to propel market
  • 13.3.3 GERMANY
    • 13.3.3.1 Presence of leading exoskeleton manufacturers and startups to complement revenue growth
  • 13.3.4 FRANCE
    • 13.3.4.1 Strong public and private investment in MedTech to boost market
  • 13.3.5 ITALY
    • 13.3.5.1 Strong collaboration between research institutes and industry to drive market
  • 13.3.6 POLAND
    • 13.3.6.1 Strategic partnerships with global exoskeleton providers to drive market
  • 13.3.7 NORDICS
    • 13.3.7.1 Academic and institutional R&D in robotics to drive market
  • 13.3.8 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 Military investment in wearable robotics for logistics and mobility to boost market
  • 13.4.3 JAPAN
    • 13.4.3.1 Rapidly aging population and government support to create lucrative market growth opportunities
  • 13.4.4 SOUTH KOREA
    • 13.4.4.1 Advancements in lightweight, AI-integrated wearable robotics systems to drive market
  • 13.4.5 INDIA
    • 13.4.5.1 Military adoption for enhanced soldier endurance and injury prevention to boost market
  • 13.4.6 AUSTRALIA
    • 13.4.6.1 High healthcare spending to encourage adoption of advanced assistive technologies and boost demand
  • 13.4.7 INDONESIA
    • 13.4.7.1 High paraplegic population demanding affordable mobility rehabilitation solutions to drive market
  • 13.4.8 MALAYSIA
    • 13.4.8.1 Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities
  • 13.4.9 THAILAND
    • 13.4.9.1 Government-backed research funding to boost exoskeleton technology development
  • 13.4.10 VIETNAM
    • 13.4.10.1 Increased research initiatives by domestic academic and medical institutions to drive market
  • 13.4.11 REST OF ASIA PACIFIC
• 13.5 REST OF THE WORLD
  • 13.5.1 MACROECONOMIC OUTLOOK FOR ROW
  • 13.5.2 MIDDLE EAST
    • 13.5.2.1 Bahrain
      • 13.5.2.1.1 Growing adoption of smart transportation and home automation to drive demand
    • 13.5.2.2 Kuwait
      • 13.5.2.2.1 Focus on improving healthcare accessibility and patient outcomes to fuel market
    • 13.5.2.3 Oman
      • 13.5.2.3.1 Rising prevalence of neurological and musculoskeletal disorders to drive market
    • 13.5.2.4 Qatar
      • 13.5.2.4.1 Strategic focus on defense modernization and soldier performance to increase market demand
    • 13.5.2.5 Saudi Arabia
      • 13.5.2.5.1 Vision 2030 focus on healthcare innovation and technology adoption to fuel market
    • 13.5.2.6 UAE
      • 13.5.2.6.1 Investment in R&D of intelligent robotic systems to drive market
    • 13.5.2.7 Rest of the Middle East
  • 13.5.3 SOUTH AMERICA
    • 13.5.3.1 Partnerships with global exoskeleton technology providers and manufacturers to support market
  • 13.5.4 AFRICA
  • 13.5.5 SOUTH AFRICA
    • 13.5.5.1 Focus on improving worker safety in high-risk mining operations to drive market
  • 13.5.6 OTHER AFRICAN COUNTRIES

14 COMPETITIVE LANDSCAPE

• 14.1 OVERVIEW
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022-FEBRUARY 2025
• 14.3 REVENUE ANALYSIS, 2019-2023
• 14.4 MARKET SHARE ANALYSIS, 2024
• 14.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
• 14.6 BRAND/PRODUCT COMPARISON
• 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 14.7.1 STARS
  • 14.7.2 EMERGING LEADERS
  • 14.7.3 PERVASIVE PLAYERS
  • 14.7.4 PARTICIPANTS
  • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 14.7.5.1 Company footprint
    • 14.7.5.2 Region footprint
    • 14.7.5.3 Vertical footprint
    • 14.7.5.4 Type footprint
    • 14.7.5.5 Body part footprint
• 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.8.1 PROGRESSIVE COMPANIES
  • 14.8.2 RESPONSIVE COMPANIES
  • 14.8.3 DYNAMIC COMPANIES
  • 14.8.4 STARTING BLOCKS
  • 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
    • 14.8.5.1 Detailed list of startups/SMEs
    • 14.8.5.2 Competitive benchmarking of key startups/SMEs
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS
  • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 EKSO BIONICS
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products/Solutions/Services offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product launches
      • 15.1.1.3.2 Deals
      • 15.1.1.3.3 Other developments
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Key strengths/Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses and competitive threats
  • 15.1.2 OTTOBOCK
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products/Solutions/Services offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product launches
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Key strengths/Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses and competitive threats
  • 15.1.3 DIH MEDICAL
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products/Solutions/Services offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Key strengths/Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses and competitive threats
  • 15.1.4 COMAU
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products/Solutions/Services offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Product launches
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Key strengths/Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses and competitive threats
  • 15.1.5 MYOMO INC.
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products/Solutions/Services offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches
      • 15.1.5.3.2 Other developments
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Key strengths/Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses and competitive threats
  • 15.1.6 CYBERDYNE INC.
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products/Solutions/Services offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Expansions
  • 15.1.7 LIFEWARD LTD.
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products/Solutions/Services offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Deals
  • 15.1.8 HYUNDAI MOTOR GROUP ROBOTICS LAB.
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products/Solutions/Services offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Product launches
      • 15.1.8.3.2 Deals
  • 15.1.9 B-TEMIA
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products/Solutions/Services offered
  • 15.1.10 REX BIONICS LTD.
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products/Solutions/Services offered
• 15.2 OTHER PLAYERS
  • 15.2.1 ABLE HUMAN MOTION
  • 15.2.2 LAEVO EXOSKELETONS
  • 15.2.3 GERMAN BIONIC SYSTEMS GMBH
  • 15.2.4 LEVITATE TECHNOLOGIES, INC.
  • 15.2.5 FOURIER
  • 15.2.6 TREXO ROBOTICS
  • 15.2.7 WANDERCRAFT
  • 15.2.8 AGADE
  • 15.2.9 EUROPE TECHNOLOGIES
  • 15.2.10 GOGOA.EU
  • 15.2.11 ARCHELIS INC.
  • 15.2.12 P&S MECHANICS CO., LTD.
  • 15.2.13 RB3D
  • 15.2.14 JAPET MEDICAL DEVICES
  • 15.2.15 PROTESO S.R.L.

16 APPENDIX

• 16.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.2 CUSTOMIZATION OPTIONS
• 16.3 RELATED REPORTS
• 16.4 AUTHOR DETAILS